VICPOTCPharmaceutical PreparationsFiscal year ends December 31
Vicapsys Life Sciences, Inc.
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Jan 10, 2025
$0.40+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $13.73M
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Vicapsys Life Sciences from other investors
No posts about VICP yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.